News

Net profit of Pfizer rose 6.63% to Rs 204.47 crore in the quarter ended June 2026 as against Rs 191.75 crore during the previous quarter ended June 2025. Sales rose 8.31% to Rs 653.17 crore in the quarter ended June 2026 as against Rs 603.05 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales653.17603.05 8 OPM %37.9034.83 - PBDT290.94273.94 6 PBT276.68259.53 7 NP204.47191.75 7 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 28 July 2026.

Pfizer announced that the 75th Annual General Meeting(AGM) of the company will be held on 28 July 2026.

Pfizer announced that the Board of Directors of the Company at its meeting held on 12 May 2026, inter alia, have recommended the final dividend of Rs 75 per equity Share (i.e. 750%) , subject to the approval of the shareholders.

Net profit of Pfizer declined 39.62% to Rs 199.82 crore in the quarter ended March 2026 as against Rs 330.94 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 629.23 crore in the quarter ended March 2026 as against Rs 591.91 crore during the previous quarter ended March 2025.For the full year,net profit declined 5.88% to Rs 722.43 crore in the year ended March 2026 as against Rs 767.60 crore during the previous year ended March 2025. Sales rose 10.45% to Rs 2519.65 crore in the year ended March 2026 as against Rs 2281.35 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales629.23591.91 6 2519.652281.35 10 OPM %37.5038.43 -35.8832.45 - PBDT274.56269.39 2 1082.56904.07 20 PBT259.78252.99 3 1024.83843.28 22 NP199.82330.94 -40 722.43767.60 -6 Powered by Capital Market - Live News